Literature DB >> 14567393

The spindle checkpoint: from normal cell division to tumorigenesis.

Carla S Lopes1, Claudio E Sunkel.   

Abstract

Faithful chromosome segregation during each cell division is regulated by the spindle checkpoint. This surveillance mechanism monitors kinetochore-microtubule attachment and the integrity of the mitotic apparatus, delaying mitotic exit until all chromosomes are properly aligned at the metaphase plate. Failure of this mechanism can generate gross aneuploidy. Since its discovery, mutations in genes involved in the spindle checkpoint response were predicted to be serious candidates for the chromosomal instability phenotype observed in many tumors. During the last few years, significant advances have been made in understanding the molecular basis of the spindle checkpoint. However, many studies of tumor cell lines and primary cancer isolates have failed to show a direct correlation with mutations in spindle checkpoint components. Nevertheless, it was shown that many tumor cells have an abnormal spindle checkpoint. Therefore, better understanding of the molecular mechanisms involved in regulation of spindle checkpoint response are expected to provide important clues regarding the mechanisms underlying the emergence of neoplasia.

Entities:  

Mesh:

Year:  2003        PMID: 14567393     DOI: 10.1016/S0188-4409(03)00024-9

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  3 in total

1.  Genetic variation in the major mitotic checkpoint genes and risk of breast cancer: a multigenic study on cancer susceptibility.

Authors:  Ping Wang; Yong Wang; Haichao Yan; Qiuping Xie; Liang Zhao; Shaoming Xu; Qunzi Zhao
Journal:  Tumour Biol       Date:  2014-04-08

Review 2.  Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.

Authors:  Michelle McBride; Padmashree C G Rida; Ritu Aneja
Journal:  Mol Aspects Med       Date:  2015-05-27

3.  Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.

Authors:  Taryne Chong; Amila Sarac; Cindy Q Yao; Linda Liao; Nicola Lyttle; Paul C Boutros; John M S Bartlett; Melanie Spears
Journal:  J Ovarian Res       Date:  2018-04-04       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.